Status
Conditions
Treatments
About
This study aims at identifying the neurohormonal biomarkers that characterize individuals at risk of greater metabolic adaptation to weight loss, a disproportionate decline in resting metabolic rate during and after weight loss.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
BMI > or = 30 any ethnicity
Exclusion criteria
weight > or = 400 lbs.
diabetes (type 2 or type 1)
hypertension
heart disease
kidney disease
liver disease
active cancer
post solid organ or bone marrow transplant
HIV/AIDS
pregnancy
breastfeeding
current smoker
current recreational drug use
Primary purpose
Allocation
Interventional model
Masking
60 participants in 1 patient group
Loading...
Central trial contact
Lisa L Morselli, MD PhD; Roland James
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal